Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
Merck
Colorcon
Harvard Business School
McKesson
Baxter

Last Updated: January 23, 2020

DrugPatentWatch Database Preview

Litigation Details for OTSUKA PHARMACEUTICAL CO., LTD. v. MYLAN INC. (D.N.J. 2014)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

OTSUKA PHARMACEUTICAL CO., LTD. v. MYLAN INC. (D.N.J. 2014)

Docket   Start Trial Date Filed 2014-07-11
Court District Court, D. New Jersey Date Terminated 2018-03-05
Cause 35:271 Patent Infringement Assigned To Jerome B. Simandle
Jury Demand None Referred To Karen M. Williams
Parties MYLAN INC.; MYLAN LABORATORIES LIMITED; MYLAN PHARMACEUTICALS INC.; OTSUKA PHARMACEUTICAL CO., LTD.
Patents 7,053,092; 8,017,615; 8,580,796; 8,642,600; 8,642,760; 8,759,350
Attorneys ARNOLD B. CALMANN; BRIAN RONALD ZURICH; CHRISTOPHER P. SOPER; JEFFREY S. SOOS; JOHN F. BRENNER; JOHN MICHAEL VAZQUEZ; KATHERINE ANN ESCANLAR; LEAH WOOD FEINMAN; MELISSA ANNE CHUDEREWICZ
Firms Alston & Bird LLP; Critchley Kinum & Vazquez LLC; Pepper Hamilton LLP
Link to Docket External link to docket
Small Molecule Drugs cited in OTSUKA PHARMACEUTICAL CO., LTD. v. MYLAN INC.
The small molecule drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for OTSUKA PHARMACEUTICAL CO., LTD. v. MYLAN INC. (D.N.J. 2014)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 for Summary Judgment of Invalidity of U.S. Patent No. 8,017,615 (Joining Apotex's Motion -- see ECF Nos.…Judgment of Noninfringement of U.S. Patent Nos. 8,642,760; 8,017,615; and 8,580,796, 209 MOTION to Seal…2014 5 March 2018 1:14-cv-04508 830 Patent None District Court, D. New Jersey External link to document
0000-00-00 1 U.S. Patent No. 8,642,760 (“the ’760 patent”), U.S. Patent No. 7,053,092 (“the ’092 patent”) and U.S. Patent…of U.S. Patent No. 8,017,615 (“the ’615 patent”), U.S. Patent No. 8,580,796 (“the ’796 patent”), U.S.… Patent No. 8,642,600 (“the ’600 patent”) arising under the United States patent laws, Title 35, United… FIRST COUNT FOR PATENT INFRINGEMENT 12. The U.S. Patent and Trademark Office (“PTO…the ’615 patent is attached as Exhibit A. 13. Otsuka is the owner of the ’615 patent by virtue External link to document
0000-00-00 143 Judgment of Noninfringement Concerning U.S. Patent No. 8,759,350. ORDERED, ADJUDGED that PARTIAL SUMMARY …Complaint 86 concerning infringement of U.S. Patent No. 8,759,350. Signed by Chief Judge Jerome B. Simandle…2014 5 March 2018 1:14-cv-04508 830 Patent None District Court, D. New Jersey External link to document
2016-02-19 147 Entry of Summary Judgment Concerning U.S. Patent No. 8,759,350, Certification of Judgment Under Rule 54… 11 July 2014 1:14-cv-04508 830 Patent None District Court, D. New Jersey External link to document
2016-03-07 151 Entry of Summary Judgment Concerning U.S. Patent No. 8,759,350, Certification of Judgment Under Rule 54… 11 July 2014 1:14-cv-04508 830 Patent None District Court, D. New Jersey External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Johnson and Johnson
AstraZeneca
Colorcon
McKinsey
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.